A number of research firms have changed their ratings and price targets for IDEX Corporation (NYSE: IEX):

  • 8/4/2017 – IDEX Corporation had its “hold” rating reaffirmed by analysts at Jefferies Group LLC. They now have a $91.00 price target on the stock.
  • 7/28/2017 – IDEX Corporation was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $129.00 price target on the stock. According to Zacks, “IDEX reported solid second-quarter 2017 results, driven by healthy year-over-year increase in earnings and revenues that also beat the respective Zacks Consensus Estimates. With a flexible yet disciplined focus on cost and productivity, the company expects to successfully tap newer markets to continuously boost its revenue. IDEX further intends to optimize its cost structure, increase competitiveness and reallocate resources to improve margins. IDEX generated solid order levels and witnessed significantly higher demand in the North American industrial markets with a marked improvement in larger capital projects. Management also raised its earlier guidance for 2017 on robust demand patterns and healthy growth dynamics. IDEX outperformed the industry year to date. However, IDEX’s performance is exposed to the frailties in the U.S. and international markets, while its acquisition spree often becomes a drag on the profitability.”
  • 7/28/2017 – IDEX Corporation had its “hold” rating reaffirmed by analysts at BMO Capital Markets. They now have a $110.00 price target on the stock.
  • 7/27/2017 – IDEX Corporation had its “sector perform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $115.00 price target on the stock, up previously from $109.00.
  • 7/27/2017 – IDEX Corporation was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “IDEX reported solid second-quarter 2017 results, driven by healthy year-over-year increase in earnings and revenues that also beat the respective Zacks Consensus Estimates. With a flexible yet disciplined focus on cost and productivity, the company expects to successfully tap newer markets to continuously boost its revenue. IDEX further intends to optimize its cost structure, increase competitiveness and reallocate resources to improve margins. Management also raised its earlier guidance for 2017 on robust demand patterns and healthy growth dynamics. IDEX outperformed the industry year to date. However, IDEX’s performance is exposed to the frailties in the U.S. and international markets, while its acquisition spree often becomes a drag on the profitability. Huge recurring R&D expenses further increase operating costs and reduce its price control over products, which often lead to loss of market share, lower sales and operating margins.”
  • 7/25/2017 – IDEX Corporation was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating.
  • 7/11/2017 – IDEX Corporation was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $128.00 price target on the stock. According to Zacks, “In first-quarter 2017, IDEX witnessed record order levels and modest organic growth on a diligent execution of operational plans. IDEX is currently striving to expand its businesses in the emerging markets by focusing on a holistic growth model and actively balancing organic and inorganic growth. With a flexible yet disciplined focus on cost and productivity, the company expects to successfully tap newer markets to continuously boost its revenue. IDEX further intends to optimize its cost structure, increase its competitiveness and reallocate resources to improve its profitability. Management also raised its earlier guidance for 2017 on robust demand patterns and healthy growth dynamics. IDEX outperformed the industry year to date. However, IDEX’s performance is exposed to the frailties in the U.S. and international markets, while its acquisition spree often becomes a drag on the profitability.”
  • 7/5/2017 – IDEX Corporation had its price target raised by analysts at Cowen and Company from $80.00 to $95.00. They now have a “market perform” rating on the stock.
  • 6/21/2017 – IDEX Corporation was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “In first-quarter 2017, IDEX witnessed record order levels and modest organic growth on diligent execution of operational plans. With a flexible yet disciplined focus on cost and productivity, the company expects to successfully tap newer markets to continuously boost its revenue. IDEX intends to optimize its cost structure, increase its competitiveness and reallocate resources to improve profitability. Management further raised its earlier guidance for 2017 on robust demand patterns. IDEX also outperformed the industry year to date. However, IDEX’s performance is exposed to the frailties in the U.S. and international markets, while its acquisition spree often becomes a drag on the profitability. The company has huge recurring R&D expenses that increase its operating costs. This also reduces IDEX’s price control over its products, which may further result in the loss of market share, reduced sales and lower operating margins.”
  • 6/21/2017 – IDEX Corporation had its “neutral” rating reaffirmed by analysts at Seaport Global Securities.
  • 6/20/2017 – IDEX Corporation was upgraded by analysts at BidaskClub from a “buy” rating to a “strong-buy” rating.

IDEX Corporation (NYSE:IEX) traded down 2.35% during midday trading on Thursday, hitting $113.04. 305,776 shares of the stock were exchanged. The firm has a market capitalization of $8.64 billion, a price-to-earnings ratio of 30.30 and a beta of 1.20. IDEX Corporation has a one year low of $82.05 and a one year high of $118.08. The company has a 50 day moving average price of $114.15 and a 200 day moving average price of $102.40.

IDEX Corporation (NYSE:IEX) last announced its quarterly earnings results on Tuesday, July 25th. The industrial products company reported $1.08 earnings per share for the quarter, beating analysts’ consensus estimates of $1.06 by $0.02. The business had revenue of $573.40 million for the quarter, compared to the consensus estimate of $568.43 million. IDEX Corporation had a net margin of 13.12% and a return on equity of 19.01%. IDEX Corporation’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same period last year, the company posted $0.99 EPS. Equities analysts anticipate that IDEX Corporation will post $4.22 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Monday, July 31st. Investors of record on Friday, July 14th were given a $0.37 dividend. The ex-dividend date was Wednesday, July 12th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 1.31%. IDEX Corporation’s dividend payout ratio is 39.68%.

In related news, Chairman Andrew K. Silvernail sold 50,000 shares of the stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $115.00, for a total value of $5,750,000.00. Following the sale, the chairman now directly owns 142,114 shares in the company, valued at approximately $16,343,110. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.00% of the company’s stock.

IDEX Corporation (IDEX) operates an applied solutions business that sells pumps, flow meters and other fluidics systems, and components and engineered products. The Company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST) and Fire & Safety/Diversified Products (FSDP).

Receive News & Ratings for IDEX Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.